Diabetes induces aberrant DNA methylation in the proximal tubules of the kidney

Journal of the American Society of Nephrology

Volumn 26, Issue 10, 2015, Pages 2388-2397

  Marumo, Takeshi ^a,c   Yagi, Shintaro ^b   Kawarazaki, Wakako ^a   Nishimoto, Mitsuhiro ^a   Ayuzawa, Nobuhiro ^a   Watanabe, Atsushi ^a   Ueda, Kohei ^a   Hirahashi, Junichi ^d   Hishikawa, Keiichi ^b   Sakurai, Hiroyuki ^e   Shiota, Kunio ^b   Fujita, Toshiro ^a,c  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^d KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CYTOCHROME P450 4A; CYTOCHROME P450 4A10; DNA; DNA METHYLTRANSFERASE; EPITHELIAL SODIUM CHANNEL; GLUCOSE; GLUCOSE 6 PHOSPHATE; GLUCOSE TRANSPORTER 5; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; HISTONE DEACETYLASE; MESSENGER RNA; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 4; PIOGLITAZONE; SCATTER FACTOR RECEPTOR; SODIUM CHLORIDE COTRANSPORTER; SODIUM GLUCOSE COTRANSPORTER 2; SODIUM POTASSIUM CHLORIDE COTRANSPORTER 2; SOLUTE CARRIER ORGANIC ANION TRANSPORTER 1A1; UNCLASSIFIED DRUG;

AGT GENE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CLDN18 GENE; CONTROLLED STUDY; DEMETHYLATION; DIABETIC NEPHROPATHY; DNA METHYLATION; GENE; GENE EXPRESSION; GENE IDENTIFICATION; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HISTONE ACETYLATION; HUMAN; HUMAN CELL; IN SITU HYBRIDIZATION; KIDNEY PROXIMAL TUBULE; KIF20B GENE; MALE; MOUSE; NONHUMAN; PCK1 GENE; PRIORITY JOURNAL; PROMOTER REGION; TRANSCRIPTION INITIATION SITE; ANIMAL; C57BL MOUSE; EXPERIMENTAL DIABETES MELLITUS; GENETICS; METABOLISM;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DNA METHYLATION; KIDNEY TUBULES, PROXIMAL; MALE; MICE; MICE, INBRED C57BL;

EID: 84938550023     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2014070665     Document Type: Article

References (42)

1. Gregg EW, Li Y, Wang J, Burrows NR, Ali MK, Rolka D, Williams DE, Geiss L: Changes in diabetes-related complications in the United States, 1990-2010. N Engl J Med 370: 1514-1523, 2014.
2. Kirchner H, Osler ME, Krook A, Zierath JR: Epigenetic flexibility in metabolic regulation: Disease cause and prevention? Trends Cell Biol 23: 203-209, 2013.
3. Pirola L, Balcerczyk A, Okabe J, El-Osta A: Epigenetic phenomena linked to diabetic complications. Nat Rev Endocrinol 6: 665-675, 2010.
4. Barrès R, Osler ME, Yan J, Rune A, Fritz T, Caidahl K, Krook A, Zierath JR: Non-CpG methylation of the PGC-1alpha promoter through DNMT3B controls mitochondrial density. Cell Metab 10: 189-198, 2009.
5. Hasegawa K, Wakino S, Simic P, Sakamaki Y, Minakuchi H, Fujimura K, Hosoya K, Komatsu M, Kaneko Y, Kanda T, Kubota E, Tokuyama H, Hayashi K, Guarente L, Itoh H: Renal tubular Sirt1 attenuates diabetic albuminuria by epigenetically suppressing Claudin-1 overexpression in podocytes. Nat Med 19: 1496-1504, 2013.
6. Ko YA, Mohtat D, Suzuki M, Park AS, Izquierdo MC, Han SY, Kang HM, Si H, Hostetter T, Pullman JM, Fazzari M, Verma A, Zheng D, Greally JM, Susztak K: Cytosine methylation changes in enhancer regions of core pro-fibrotic genes characterize kidney fibrosis development. Genome Biol 14: R108, 2013.
7. Mather A, Pollock C: Glucose handling by the kidney. Kidney Int Suppl (120, Suppl, Suppl): S1-S6, 2011.
8. Vallon V, Thomson SC: Renal function in diabetic disease models: The tubular systemin the pathophysiology of the diabetic kidney. Annu Rev Physiol 74: 351-375, 2012.
9. Ziller MJ, Gu H, Müller F, Donaghey J, Tsai LT, Kohlbacher O, De-Jager PL, Rosen ED, Bennett DA, Bernstein BE, Gnirke A, Meissner A: Charting a dynamicDNAmethylation landscape of the human genome. Nature 500: 477-481, 2013.
10. Yagi S, Hirabayashi K, Sato S, Li W, Takahashi Y, Hirakawa T, Wu G, Hattori N, Hattori N, Ohgane J, Tanaka S, Liu XS, Shiota K: DNA methylation profile of tissue-dependent and differentially methylated regions (T-DMRs) in mouse promoter regions demonstrating tissuespecific gene expression. Genome Res 18: 1969-1978, 2008.
11. Kikuchi R, Yagi S, Kusuhara H, Imai S, Sugiyama Y, Shiota K: Genomewide analysis of epigenetic signatures for kidney-specific transporters. Kidney Int 78: 569-577, 2010.
12. Barres R, Kirchner H, RasmussenM, Yan J, Kantor FR, Krook A, Näslund E, Zierath JR: Weight loss after gastric bypass surgery in human obesity remodels promoter methylation. Cell Reports 3: 1020-1027, 2013.
13. Sekine M, Taya C, Shitara H, Kikkawa Y, Akamatsu N, Kotani M, Miyazaki M, Suzuki A, Yonekawa H: The cis-regulatory element Gsl5 is indispensable for proximal straight tubule cell-specific transcription of core 2 beta-1, 6-N-acetylglucosaminyltransferase in the mouse kidney. J Biol Chem 281: 1008-1015, 2006.
14. Jiang S, Tanaka T, Iwanari H, Hotta H, Yamashita H, Kumakura J, Watanabe Y, Uchiyama Y, Aburatani H, Hamakubo T, Kodama T, Naito M: Expression and localization of P1 promoter-driven hepatocyte nuclear factor-4alpha (HNF4alpha) isoforms in human and rats. Nucl Recept 1: 5, 2003.
15. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA: 10-year followup of intensive glucose control in type 2 diabetes. N Engl J Med 359: 1577-1589, 2008.
16. Sassi Y, Lipskaia L, Vandecasteele G, Nikolaev VO, Hatem SN, Cohen Aubart F, Russel FG, Mougenot N, Vrignaud C, Lechat P, Lompré AM, Hulot JS: Multidrug resistance-associated protein 4 regulates cAMPdependent signaling pathways and controls human and rat SMC proliferation. J Clin Invest 118: 2747-2757, 2008.
17. Ying J, Stuart D, Hillas E, Gociman BR, Ramkumar N, Lalouel JM, Kohan DE: Overexpression of mouse angiotensinogen in renal proximal tubule causes salt-sensitive hypertension in mice. Am J Hypertens 25: 684-689, 2012.
18. Lo CS, Chang SY, Chenier I, Filep JG, Ingelfinger JR, Zhang SL, Chan JS: Heterogeneous nuclear ribonucleoprotein F suppresses angiotensinogen gene expression and attenuates hypertension and kidney injury in diabetic mice. Diabetes 61: 2597-2608, 2012.
19. Nakagawa K, Holla VR, Wei Y, Wang WH, Gatica A, Wei S, Mei S, Miller CM, Cha DR, Price E Jr, Zent R, Pozzi A, Breyer MD, Guan Y, Falck JR, Waterman MR, Capdevila JH: Salt-sensitive hypertension is associated with dysfunctional Cyp4a10 gene and kidney epithelial sodium channel. J Clin Invest 116: 1696-1702, 2006.
20. Cruzado JM, Lloberas N, Torras J, Riera M, Fillat C, Herrero-Fresneda I, Aran JM, Alperovich G, Vidal A, Grinyó JM: Regression of advanced diabetic nephropathy by hepatocyte growth factor gene therapy in rats. Diabetes 53: 1119-1127, 2004.
21. Sugawara-Yokoo M, Suzuki T, Matsuzaki T, Naruse T, Takata K: Presence of fructose transporter GLUT5 in the S3 proximal tubules in the rat kidney. Kidney Int 56: 1022-1028, 1999.
22. Yu AS: Claudins and the kidney [published online ahead of print June 19, 2014]. J Am Soc Nephrol doi:10.1681/ASN.2014030284.
23. Miki H, Setou M, Kaneshiro K, Hirokawa N: All kinesin superfamily protein, KIF, genes in mouse and human. Proc Natl Acad Sci U S A 98: 7004-7011, 2001.
24. More VR, Wen X, Thomas PE, Aleksunes LM, Slitt AL: Severe diabetes and leptin resistance cause differential hepatic and renal transporter expression in mice. Comp Hepatol 11: 1, 2012.
25. Ahrens M, Ammerpohl O, von-Schönfels W, Kolarova J, Bens S, Itzel T, Teufel A, Herrmann A, Brosch M, Hinrichsen H, Erhart W, Egberts J, Sipos B, Schreiber S, Häsler R, Stickel F, Becker T, Krawczak M, Röcken C, Siebert R, Schafmayer C, Hampe J: DNA methylation analysis in nonalcoholic fatty liver disease suggests distinct disease-specific and remodeling signatures after bariatric surgery. Cell Metab 18: 296-302, 2013.
26. Kaelin WG Jr, McKnight SL: Influence of metabolism on epigenetics and disease. Cell 153: 56-69, 2013.
27. Takizawa F, Mizutani S, Ogawa Y, Sawada N: Glucose-independent persistence of PAI-1 gene expression and H3K4 tri-methylation in type 1 diabetic mouse endothelium: implication in metabolic memory. Biochem Biophys Res Commun 433: 66-72, 2013.
28. Makino H, Miyamoto Y, Sawai K, Mori K, Mukoyama M, Nakao K, Yoshimasa Y, Suga S: Altered gene expression related to glomerulogenesis and podocyte structure in early diabetic nephropathy of db/db mice and its restoration by pioglitazone. Diabetes 55: 2747-2756, 2006.
29. Volkmar M, Dedeurwaerder S, Cunha DA, Ndlovu MN, Defrance M, Deplus R, Calonne E, Volkmar U, Igoillo-Esteve M, Naamane N, Del-Guerra S, Masini M, Bugliani M, Marchetti P, Cnop M, Eizirik DL, Fuks F: DNA methylation profiling identifies epigenetic dysregulation in pancreatic islets fromtype 2 diabetic patients. EMBO J 31: 1405-1426, 2012.
30. Stanescu DE, Hughes N, Kaplan B, Stanley CA, De-León DD: Novel presentations of congenital hyperinsulinism due to mutations in the MODY genes: HNF1A and HNF4A. J Clin Endocrinol Metab 97: E2026-E2030, 2012.
31. Ruan HB, Singh JP, Li MD, Wu J, Yang X: Cracking the O-GlcNAc code in metabolism. Trends Endocrinol Metab 24: 301-309, 2013.
32. Susztak K, Böttinger E, Novetsky A, Liang D, Zhu Y, Ciccone E, Wu D, Dunn S, McCue P, Sharma K: Molecular profiling of diabetic mouse kidney reveals novel genes linked to glomerular disease. Diabetes 53: 784-794, 2004.
33. Hasegawa M, Kusuhara H, Adachi M, Schuetz JD, Takeuchi K, Sugiyama Y: Multidrug resistance-associated protein 4 is involved in the urinary excretion of hydrochlorothiazide and furosemide. J AmSoc Nephrol 18: 37-45, 2007.
34. Holla VR, Adas F, Imig JD, Zhao X, Price E Jr, Olsen N, Kovacs WJ, Magnuson MA, Keeney DS, Breyer MD, Falck JR, Waterman MR, Capdevila JH: Alterations in the regulation of androgen-sensitive Cyp 4a monooxygenases cause hypertension. Proc Natl Acad Sci U S A 98: 5211-5216, 2001.
35. Kobori H, Nangaku M, Navar LG, Nishiyama A: The intrarenal reninangiotensin system: From physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev 59: 251-287, 2007.
36. Matsusaka T, Niimura F, Shimizu A, Pastan I, Saito A, Kobori H, Nishiyama A, Ichikawa I: Liver angiotensinogen is the primary source of renal angiotensin II. J Am Soc Nephrol 23: 1181-1189, 2012.
37. Reudelhuber TL: Where hypertension happens. J Clin Invest 123: 1934-1936, 2013.
38. Ortiz-Melo DI, Spurney RF: Special deLIVERy: podocyte injury promotes renal angiotensin IIgeneration fromliver-derivedangiotensinogen. Kidney Int 85: 1009-1011, 2014.
39. Hovestadt V, Jones DT, Picelli S, Wang W, Kool M, Northcott PA, Sultan M, Stachurski K, Ryzhova M, Warnatz HJ, Ralser M, Brun S, Bunt J, Jäger N, Kleinheinz K, Erkek S, Weber UD, Bartholomae CC, von-Kalle C, Lawerenz C, Eils J, Koster J, Versteeg R, Milde T, Witt O, Schmidt S, Wolf S, Pietsch T, Rutkowski S, Scheurlen W, Taylor MD, Brors B, Felsberg J, Reifenberger G, Borkhardt A, Lehrach H, Wechsler-Reya RJ, Eils R, Yaspo ML, Landgraf P, Korshunov A, Zapatka M, Radlwimmer B, Pfister SM, Lichter P: Decoding the regulatory landscape of medulloblastoma using DNA methylation sequencing. Nature 510: 537-541, 2014.
40. Breyer MD, Böttinger E, Brosius FC 3rd, Coffman TM, Harris RC, Heilig CW, Sharma K; AMDCC: Mouse models of diabetic nephropathy. J Am Soc Nephrol 16: 27-45, 2005.
41. Tesch GH, Lim AK: Recent insights into diabetic renal injury from the db/db mouse model of type 2 diabetic nephropathy. Am J Physiol Renal Physiol 300: F301-F310, 2011.
42. Wu G, Hirabayashi K, Sato S, Akiyama N, Akiyama T, Shiota K, Yagi S: DNA methylation profile of Aire-deficient mouse medullary thymic epithelial cells. BMC Immunol 13: 58, 2012.